We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Dec 2018 16:25

RNS Number : 7360K
Nucleus Financial Group PLC
17 December 2018
 

17 December 2018

Nucleus Financial Group plc

("Nucleus" or the "Company")

Share purchases under the Company's Share Incentive Plan

Director/PDMR Shareholding

 

Nucleus (AIM: NUC) announces that, further to the details included in the Company's AIM admission document in respect of the all-employee Share Incentive Plan ("SIP"), it has received notification that the first purchase of ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") by the SIP trustee on behalf of participating employees took place on 12 December 2018.

Nucleus supports the principles of wider share ownership amongst all its people and the SIP is designed to help employees acquire the Company's Ordinary Shares in a tax efficient way. The Nucleus SIP is an all-employee share ownership plan approved by HM Revenue and Customs, under which eligible employees are able to purchase Ordinary Shares in the Company via the SIP trustee, either by monthly salary deductions or by investing a lump sum (up to the value of £1,800) in the plan. The Ordinary Shares purchased are known as "Partnership Shares" and for each Partnership Share purchased, participants are awarded one matching free Ordinary Share (a "Matching Share"), which the SIP trustee purchases, funded by the Company. Partnership and Matching Shares must be held in the SIP for five years from the date of their respective purchase before they can be withdrawn by the employee free of income tax and National Insurance contributions. Purchases of Partnership Shares and Matching Shares are anticipated to take place on a monthly basis going forwards on behalf of those employees participating during the relevant month.

Details of the Partnership Shares and Matching Shares purchased by the SIP trustee on behalf of PDMRs are set out in the table below. The Partnership and Matching Shares were purchased by the SIP trustee on behalf of the below PDMRs at a price of 135 pence per share.

Name/Position

Number ofPartnership Shares

Number of Matching Shares

Total resulting interest in Ordinary Shares*

David Ferguson, Chief Executive Officer

111

111

1,810,410 (2.37%)

Andrew Smith, Chief Technology Officer

1,333

1,333

377,619 (0.49%)

Barry Neilson, Chief Customer Officer

1,333

1,333

551,722 (0.72%)

Kirsty Lynagh, Chief people officer

111

111

78,302 (0.10%)

 * Includes Ordinary Shares held by closely associated persons and the SIP trustee on behalf of the PDMR

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. David Ferguson

2. Andrew Smith

3. Barry Neilson

4. Kirsty Lynagh

 

2.

Reason for the notification

a)

Position / status

1. Chief executive officer

2. Chief technology officer

3. Chief customer officer

4. Chief people officer

 

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Nucleus Financial Group plc

b)

LEI

213800MAIAI3M7LM5950

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

c)

Description of the financial instrument

Ordinary shares of 0.1p each

 

ISIN: GB00BG226J60

d)

Nature of the transaction

Purchase and allocation of Partnership Shares and Matching Shares by the SIP trustee under the Company's SIP

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. 135p; nil

2. 135p; nil

3. 135p; nil

4. 135p; nil

1. 111; 111

2. 1,333; 1,333

3. 1,333; 1,333

4. 111; 111

 

f)

Aggregated information

 

Aggregated volume

 

Price

 

Aggregated Price(s)

Aggregated Volume(s)

1. £149.85

2. £1,799.55

3. £1,799.55

4. £149.85

1. 222

2. 2,666

3. 2,666

4. 222

 

g)

Date of the transaction

12 December 2018

 

h)

Place of the transaction

London Stock Exchange, AIM

 

    

 

 

Nucleus

Stuart Geard, Chief Financial Officer Tel: +44 (0)13 1226 9800

Shore Capital (Nominated Adviser and Broker)

Hugh Morgan Tel: +44 (0)20 7408 4090

Edward Mansfield

Daniel Bush 

Camarco (Media enquiries)

Jennifer Renwick Tel: +44 (0)20 3757 4994

Jake Thomas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBLBDDBDBBGIR
Date   Source Headline
21st Sep 20217:30 amRNSSuspension - Nucleus Financial Group plc
7th Sep 20217:00 amRNSStrategic Update and Directorate Change
23rd Aug 202112:28 pmRNSNotice of proposed cancellation of trading on AIM
10th Aug 20213:19 pmRNSForm 8.3 - Nucleus Financial Group PLC
6th Aug 20215:30 pmRNSNucleus Financial Group
6th Aug 20212:28 pmRNSDirector/PDMR Shareholding
6th Aug 20217:30 amRNSDirector changes
6th Aug 20217:00 amRNSOffer wholly unconditional
16th Jul 20217:00 amRNSQ2 2021 AUA update
18th Jun 20218:50 amRNSDirector/PDMR Shareholding
10th Jun 20219:28 amRNSForm 8.3 - Nucleus Financial Group Plc
27th May 202110:08 amRNSResult of AGM
25th May 20212:55 pmRNSUpdate on Offer Timetable and Level of Acceptances
17th May 20215:28 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSOffer unconditional as to acceptances
27th Apr 202110:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Apr 202110:14 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
21st Apr 20218:30 amRNSForm 8.3 - Nucleus Financial Group PLC
20th Apr 20218:57 amRNSForm 8.3 - Nucleus Financial Group PLC
14th Apr 20212:51 pmRNSDirector/PDMR Shareholding
14th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20212:51 pmRNSForm 8 (DD) - Nucleus Financial Group plc
13th Apr 20212:16 pmRNSDirector/PDMR Shareholding
13th Apr 202112:35 pmRNSPublication and posting of Offer Document
13th Apr 20219:48 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
13th Apr 20219:45 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
13th Apr 20217:00 amRNSQ1 2021 AUA update
9th Apr 20219:17 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
9th Apr 20218:51 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
9th Apr 20217:00 amRNSOffer Document – change of publication date
7th Apr 20213:15 pmRNSNotice of AGM - amendment
7th Apr 20218:55 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
7th Apr 20217:00 amRNSNotice of AGM
1st Apr 202110:34 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
31st Mar 202110:44 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
31st Mar 20218:55 amRNSForm 8.3 - [NUCLEUS FINANCIAL GROUP PLC]
30th Mar 202111:52 amRNSRecommended Cash Offer
29th Mar 20214:21 pmRNSDirector/PDMR Shareholding
25th Mar 20213:58 pmRNSDirector/PDMR Shareholding
25th Mar 20219:38 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
25th Mar 20218:37 amRNSForm 8.3 - Nucleus Financial Group PLC
24th Mar 20219:24 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
23rd Mar 20217:00 amRNSFinal results
19th Mar 20219:34 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 202112:08 pmGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
17th Mar 20218:59 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
16th Mar 20218:52 amRNSForm 8.3 - NUCLEUS FINANCIAL GROUP PLC
15th Mar 20214:45 pmRNSForm 8 (DD) - Nucleus Financial Group plc
15th Mar 20214:39 pmRNSDirector/PDMR Shareholding
15th Mar 202111:46 amRNSForm 8.3 - Nucleus Financial Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.